[1]
“Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity”, Reumatismo, vol. 70, no. 2, pp. 85–91, Jul. 2018, doi: 10.4081/reumatismo.2018.1027.